Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Soo Yu currently holds 1,603,467 shares of AIkido Pharma Inc. (AIKI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Soo Yu has been a net buyer of AIKI stock. They have purchased $591.0K and sold $0 worth of shares.
Soo Yu's most recent insider trade was on Jun 11, 2024, when they sold 154,559 shares at $0.00 per share.
Soo Yu serves as Executive at AIkido Pharma Inc. (AIKI). They have executed 20 insider transactions totaling $591.0K over their tenure at the company.
Soo Yu holds the position of Executive at AIkido Pharma Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Soo Yu has shown a buying trading pattern, with $591.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Soo Yu was on Dec 21, 2023, when they purchased $1.3M worth of DOMH shares. This transaction involved 630,050 shares at $2.02 per share.
Soo Yu currently owns 1,603,467 shares of AIkido Pharma Inc. (AIKI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Soo Yu's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Soo Yu has 20 Form 4 filings on record as an insider at AIkido Pharma Inc..
Set alerts for Soo Yu and 40,000+ other insiders.